製品の概要

  • 製品名
    Cyproheptadine hydrochloride
  • 製品の詳細
    Potent H1 and 5-HT2B antagonist. Non-selective receptor antagonist.
  • 生理活性の詳細
    Potent H1 and 5-HT2B antagonist (Ki and pKi values are 10 and 1.4 nM, respectively). Non-selective receptor antagonist (shows high potency (low nM) at other 5-HT, dopamine and muscarinic acetylcholine receptors. Displays antihistaminergic and antiserotonergic effects.
  • 精製度
    > 99%

製品の特性

参考文献

This product has been referenced in:
  • Paoluzzi L  et al. The anti-histaminic cyproheptadine synergizes the antineoplastic activity of bortezomib in mantle cell lymphoma through its effects as a histone deacetylase inhibitor. Br J Haematol 146:656-9 (2009). Read more (PubMed: 19604235) »
  • Droogmans S  et al. Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study. Am J Physiol Heart Circ Physiol 296:H1940-8 (2009). Read more (PubMed: 19346455) »
  • Young R  et al. Pizotyline effectively attenuates the stimulus effects of N-methyl-3,4-methylenedioxyamphetamine (MDMA). Pharmacol Biochem Behav 82:404-10 (2005). Read more (PubMed: 16253319) »
  • Moguilevsky N  et al. Stable expression of human H1-histamine-receptor cDNA in Chinese hamster ovary cells. Pharmacological characterisation of the protein, tissue distribution of messenger RNA and chromosomal localisation of the gene. Eur J Biochem 224:489-95 (1994). Read more (PubMed: 7925364) »

See 0 Publications for this product

レビューと Q&A

There are currently no Customer reviews or Questions for ab120732.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

登録